Announce only targets the evidence supports, build synergy estimates from shared data, and re-base them openly
Set public targets (adoption, synergies, dates, valuations) from evidence rather than ambition, choose targets the company controls, re-estimate synergies once the companies can share data, and treat a target raised early without evidence as a warning.
Why it ranked: function: Product, R&D & Innovation.
Score 2: function F13 +2


